1-11 of 11
hiv infections
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comment on Han et al. Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans. Diabetes Care 2017;40:218–225

María Dolores García de Lucas, Julián Olalla Sierra
Journal: Diabetes Care
Diabetes Care 2018;41(1):e6
https://doi.org/10.2337/dc17-1006
Published: 11 December 2017
View article titled, Comment on Han et al. Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans. Diabetes Care 2017;40:218–225
Open the PDF for Comment on Han et al. Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans. Diabetes Care 2017;40:218–225 in another window
Journal Articles

Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans

Jennifer H. Han, Kirsha Gordon, Julie A. Womack, Cynthia L. Gibert, David A. Leaf, David Rimland, Maria C. Rodriguez-Barradas, Gregory P. Bisson
Journal: Diabetes Care
Diabetes Care 2017;40(2):218–225
https://doi.org/10.2337/dc16-0718
Published: 15 September 2016
View article titled, Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans
Open the PDF for Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans in another window
Journal Articles

Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women in Cameroon

Jennifer Jao, MD, MPH, Marcia Wong, MD, MPH, Russell B. Van Dyke, MD, Mitchell Geffner, MD, Emmanuel Nshom, MSC, Dennis Palmer, MD, Pius T. Muffih, PHD, Elaine J. Abrams, MD, Rhoda S. Sperling, MD, Derek LeRoith, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(9):e141–e142
https://doi.org/10.2337/dc13-0968
Published: 13 August 2013
View article titled, Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women in Cameroon
Open the PDF for Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women in Cameroon in another window
Journal Articles

Type 2 Diabetes and Impaired Glucose Tolerance in Two Young Adults Infected With HIV Early in Life

David Dimock, BA, Julia B. Purdy, NP, Rohan Hazra, MD, Colleen Hadigan, MD, MPH
Journal: Diabetes Care
Diabetes Care 2011;34(3):e35
https://doi.org/10.2337/dc10-2018
Published: 17 February 2011
View article titled, Type 2 Diabetes and Impaired Glucose Tolerance in Two Young Adults Infected With HIV Early in Life
Open the PDF for Type 2 Diabetes and Impaired Glucose Tolerance in Two Young Adults Infected With HIV Early in Life in another window
Journal Articles

A1C Underestimates Glycemia in HIV Infection

Peter S. Kim, MD, Christian Woods, MD, Patrick Georgoff, BS, Dana Crum, MD, Alice Rosenberg, RN, Margo Smith, MD, Colleen Hadigan, MD, MPH
Journal: Diabetes Care
Diabetes Care 2009;32(9):1591–1593
https://doi.org/10.2337/dc09-0177
Published: 05 June 2009
View article titled, A1C Underestimates Glycemia in HIV Infection
Open the PDF for A1C Underestimates Glycemia in HIV Infection in another window
Journal Articles

HIV Therapy and Diabetes Risk

Samuel Dagogo-Jack, MD, MBBS, FRCP
Journal: Diabetes Care
Diabetes Care 2008;31(6):1267–1268
https://doi.org/10.2337/dc08-0459
Published: 01 June 2008
View article titled, HIV Therapy and Diabetes Risk
Open the PDF for HIV Therapy and Diabetes Risk in another window
Journal Articles

Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

Stephane De Wit, MD, PHD, Caroline A. Sabin, PHD, Rainer Weber, MD, Signe Westring Worm, MD, Peter Reiss, MD, PHD, Charles Cazanave, MD, Wafaa El-Sadr, MD, MPH, Antonella d'Arminio Monforte, MD, DMSC, Eric Fontas, MD, Matthew G. Law, PHD, Nina Friis-Møller, MD, PHD, Andrew Phillips, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(6):1224–1229
https://doi.org/10.2337/dc07-2013
Published: 01 June 2008
View article titled, Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: <subtitle>The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study</subtitle>
Open the PDF for Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: <subtitle>The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Errata

Journal: Diabetes Care
Diabetes Care 2007;30(2):455
https://doi.org/10.2337/dc07-er02
Published: 01 February 2007
View article titled, Errata
Open the PDF for Errata in another window
Journal Articles

Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia

Katherine Samaras, MBBS, FRACP, PHD, Handan Wand, PHD, Matthew Law, PHD, Sean Emery, PHD, David Cooper, DSC, MD, FRACP, FRCPA, Andrew Carr, MBBS, MD, FRACP, FRCPA
Journal: Diabetes Care
Diabetes Care 2007;30(1):113–119
https://doi.org/10.2337/dc06-1075
Published: 01 January 2007
View article titled, Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria: <subtitle>Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia</subtitle>
Open the PDF for Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria: <subtitle>Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia</subtitle> in another window
Journal Articles

Metabolic Syndrome Among HIV-Infected Patients: Prevalence, characteristics, and related factors

Carlos Jericó, MD, Hernando Knobel, MD, Milagro Montero, MD, Jordi Ordoñez-Llanos, MD, Ana Guelar, MD, Juan L. Gimeno, MD, Pere Saballs, MD, Jose L. López-Colomés, MD, Juan Pedro-Botet, MD
Journal: Diabetes Care
Diabetes Care 2005;28(1):132–137
https://doi.org/10.2337/diacare.28.1.132
Published: 01 January 2005
View article titled, Metabolic Syndrome Among HIV-Infected Patients: <subtitle>Prevalence, characteristics, and related factors</subtitle>
Open the PDF for Metabolic Syndrome Among HIV-Infected Patients: <subtitle>Prevalence, characteristics, and related factors</subtitle> in another window
Journal Articles

Hyperosmolar Nonketotic Diabetic Syndrome Following Treatment of Human Immunodeficiency Virus Infection With Didanosine

Medha N Munshi, MD, Rebecca E Martin, MD, Vivian A Fonseca, MD
Journal: Diabetes Care
Diabetes Care 1994;17(4):316–317
https://doi.org/10.2337/diacare.17.4.316
Published: 01 April 1994
View article titled, Hyperosmolar Nonketotic Diabetic Syndrome Following Treatment of Human Immunodeficiency Virus Infection With Didanosine
Open the PDF for Hyperosmolar Nonketotic Diabetic Syndrome Following Treatment of Human Immunodeficiency Virus Infection With Didanosine in another window